Tag: collecting duct carcinoma

Cabozantinib may be a viable first-line treatment in metastatic renal cell collecting duct carcinoma

byJohan Pushaniand1 others

April 25, 2022

1. Objective response rate was 35%, with 1 patient showing a complete response and 7 showing a partial response. 2. ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Probiotic use may decrease risk factors for metabolic syndrome
Postdischarge contacts may not significantly affect unplanned healthcare utilization or patient satisfaction
Neoadjuvant Nivolumab/Ipilimumab Vs Chemotherapy in Resectable NSCLC

No Result

View All Result